Cargando…

Activated pulmonary tuberculosis in a patient with melanoma during PD-1 inhibition: a case report

BACKGROUND: PD-1 checkpoint inhibitors have shown a robust tumor response in the treatment of various cancers. Pembrolizumab is an anti-PD-1 checkpoint antibody approved for the treatment of unresectable or metastatic melanoma in more than 40 countries. Although autoimmune pneumonitis is considered...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Wan, Zhang, Xiangmei, Li, Wenwen, Kong, Cheng, Wang, Yuanyang, Zhu, Lianyu, Xu, Ruilian, Deng, Guofang, Zhang, Peize
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204878/ https://www.ncbi.nlm.nih.gov/pubmed/30425530 http://dx.doi.org/10.2147/OTT.S178246

Ejemplares similares

Closure of pulmonary cavity of a multidrug-resistant tuberculosis patient with catheter insertion – A case report
por: Zhang, Peize, et al.
Publicado: (2020)

Extensive Radiological Manifestation in Patients with Diabetes and Pulmonary Tuberculosis: A Cross-Sectional Study
por: Zhan, Senlin, et al.
Publicado: (2022)

Challenges Faced by Multidrug-Resistant Tuberculosis Patients in Three Financially Affluent Chinese Cities
por: Zhang, Peize, et al.
Publicado: (2020)

Sleep quality and influencing factors and correlation with T-lymphocyte subpopulation counts in patients with pulmonary tuberculosis: a cross-sectional study
por: Zhang, Hailin, et al.
Publicado: (2022)

Pediatric isoniazid-resistant tuberculosis of the bone marrow manifesting as hemophagocytic syndrome: A case report
por: Zheng, Junfeng, et al.
Publicado: (2022)

Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China
por: Zhang, Peize, et al.
Publicado: (2022)

A cross-sectional study: a breathomics based pulmonary tuberculosis detection method
por: Fu, Liang, et al.
Publicado: (2023)

Clinical Evaluation of Active Tuberculosis-Related Deaths in Shenzhen, China: A Descriptive Study
por: Zhang, Peize, et al.
Publicado: (2021)

Duration and Determinants of Delayed Diagnosis with Tuberculosis in Shenzhen, China: A Cross-Sectional Study
por: Jiang, Youli, et al.
Publicado: (2022)

Pharmacokinetics of Antituberculosis Drugs in Plasma and Cerebrospinal Fluid in a Patient with Pre-Extensive Drug Resistant Tuberculosis Meningitis
por: Liang, Zhilin, et al.
Publicado: (2023)

The interaction of macrophages and CD8 T cells in bronchoalveolar lavage fluid is associated with latent tuberculosis infection
por: Yang, Qianting, et al.
Publicado: (2023)

Spiral CT Image Characteristics and Differential Diagnosis Secondary Pulmonary Tuberculosis and Lung Cancer Based on Visual Sensors
por: Zhou, Cheng, et al.
Publicado: (2022)

Performance of Xpert MTB/RIF Ultra for the Diagnosis of Pulmonary Tuberculosis Using Bronchoalveolar Lavage Samples in People Living with HIV/AIDS (PLWHA) in China: A Prospective Study
por: Zhang, Peize, et al.
Publicado: (2021)

Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR]
por: Fu, Liang, et al.
Publicado: (2023)

Case report: Significant relief of linezolid-induced peripheral neuropathy in a pre-XDR-TB case after acupuncture treatment
por: Mo, Yuping, et al.
Publicado: (2022)

PD-1 IC Inhibition Synergistically Improves Influenza A Virus-Mediated Oncolysis of Metastatic Pulmonary Melanoma
por: Sitnik, Siarhei, et al.
Publicado: (2020)

HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma
por: Huang, Fu-xue, et al.
Publicado: (2022)

Mycobacterium tuberculosis Utilizes Host Histamine Receptor H1 to Modulate Reactive Oxygen Species Production and Phagosome Maturation via the p38MAPK-NOX2 Axis
por: Mo, Siwei, et al.
Publicado: (2022)

Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis
por: Liang, Juan, et al.
Publicado: (2021)

Flubendazole inhibits PD-1 and suppresses melanoma growth in immunocompetent mice
por: Li, Yue, et al.
Publicado: (2023)

A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy
por: Wang, Yuanyuan, et al.
Publicado: (2021)

Population Pharmacokinetic Modeling of Bedaquiline among Multidrug-Resistant Pulmonary Tuberculosis Patients from China
por: Zou, Jin, et al.
Publicado: (2022)

Case report: The MSI-L/p-MMR metastatic rectal cancer patient who failed systemic therapy responds to anti-PD-1 immunotherapy after stereotactic body radiation-therapy
por: Liu, Shijin, et al.
Publicado: (2022)

Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China
por: Yuan, Xiaoliang, et al.
Publicado: (2013)

PD-1/PD-L pathway inhibits M.tb-specific CD4(+) T-cell functions and phagocytosis of macrophages in active tuberculosis
por: Shen, Lei, et al.
Publicado: (2016)

PPT1 inhibition enhances the antitumor activity of anti–PD-1 antibody in melanoma
por: Sharma, Gaurav, et al.
Publicado: (2020)

Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma
por: Sah, Vasu R., et al.
Publicado: (2021)

PPT1 inhibition enhances the antitumor activity of anti–PD-1 antibody in melanoma
por: Sharma, Gaurav, et al.
Publicado: (2022)

Tuberculosis infection in rural labor migrants in Shenzhen, China: Emerging challenge to tuberculosis control during urbanization
por: Li, Xiangwei, et al.
Publicado: (2017)

Pulmonary endothelium-derived PD-L1 induced by the H9N2 avian influenza virus inhibits the immune response of T cells
por: Zhang, Qian, et al.
Publicado: (2020)

Data analysis of PD-1 antibody in the treatment of melanoma patients
por: Li, Ting, et al.
Publicado: (2020)

The role of mitochondria in the resistance of melanoma to PD-1 inhibitors
por: Du, Fei, et al.
Publicado: (2023)

Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors
por: Zhang, Mengqi, et al.
Publicado: (2022)

Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma
por: Yan, Huiyu, et al.
Publicado: (2023)

Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
por: Waaler, Jo, et al.
Publicado: (2020)

Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
por: Lee, Jenny H., et al.
Publicado: (2020)

PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma
por: Ribas, Antoni, et al.
Publicado: (2020)

Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment
por: Ziogas, Dimitrios C., et al.
Publicado: (2023)

LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials
por: Zhao, Bai-Wei, et al.
Publicado: (2022)

PD-L1 Promotes Self-Renewal and Tumorigenicity of Malignant Melanoma Initiating Cells
por: Zheng, Fang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_idnqhdrn4v1i40a12rlhsj2n22